This company listing is no longer active
Pfizer Crecimiento futuro
Future controles de criterios 0/6
Información clave
-13.8%
Tasa de crecimiento de los beneficios
-10.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 53.5% |
Tasa de crecimiento de los ingresos | -7.7% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Good |
Última actualización | 27 Feb 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2025 | 69,449 | 15,192 | 19,209 | 21,650 | 14 |
12/31/2024 | 70,338 | 15,303 | 20,075 | 21,904 | 20 |
12/31/2023 | 70,548 | 15,120 | 18,756 | 22,520 | 18 |
12/31/2022 | 100,330 | 31,366 | 26,031 | 29,267 | N/A |
10/2/2022 | 99,878 | 29,953 | 23,362 | 26,599 | N/A |
7/3/2022 | 101,275 | 29,481 | 28,440 | 31,454 | N/A |
4/3/2022 | 92,433 | 25,410 | 31,783 | 34,583 | N/A |
12/31/2021 | 81,288 | 22,413 | 29,869 | 32,580 | N/A |
10/3/2021 | 68,877 | 19,485 | 29,769 | 32,291 | N/A |
7/4/2021 | 55,119 | 12,236 | 21,141 | 23,552 | N/A |
4/4/2021 | 46,084 | 9,032 | 13,477 | 15,808 | N/A |
12/31/2020 | 41,651 | 6,630 | 12,177 | 14,403 | N/A |
9/27/2020 | 32,334 | 212 | 10,512 | 12,547 | N/A |
6/28/2020 | 34,737 | 6,977 | 12,777 | 14,967 | N/A |
3/29/2020 | 38,137 | 9,427 | 11,702 | 14,023 | N/A |
12/31/2019 | 40,905 | 10,707 | 10,542 | 12,588 | N/A |
9/29/2019 | 53,039 | 16,211 | 10,897 | 13,557 | N/A |
6/30/2019 | 53,656 | 12,638 | 11,746 | 14,306 | N/A |
3/31/2019 | 53,859 | 11,464 | 13,146 | 15,542 | N/A |
12/31/2018 | 40,825 | 3,824 | 13,691 | 15,827 | N/A |
9/30/2018 | 53,373 | 23,808 | 16,001 | 18,178 | N/A |
7/1/2018 | 53,244 | 22,545 | 15,596 | 17,808 | N/A |
4/1/2018 | 52,673 | 21,746 | 14,924 | 17,201 | N/A |
12/31/2017 | 52,546 | 21,305 | 14,585 | 16,802 | N/A |
10/1/2017 | 52,471 | 9,791 | 13,250 | 15,463 | N/A |
7/2/2017 | 52,347 | 8,308 | 13,263 | 15,311 | N/A |
4/2/2017 | 52,598 | 7,281 | 13,621 | 15,677 | N/A |
12/31/2016 | 52,824 | 7,198 | 14,193 | 16,192 | N/A |
10/2/2016 | 53,243 | 6,270 | N/A | 15,049 | N/A |
7/3/2016 | 52,286 | 7,036 | N/A | 15,332 | N/A |
4/3/2016 | 50,992 | 7,615 | N/A | 15,816 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: PFE's earnings are forecast to decline over the next 3 years (-13.8% per year).
Beneficios vs. Mercado: PFE's earnings are forecast to decline over the next 3 years (-13.8% per year).
Beneficios de alto crecimiento: PFE's earnings are forecast to decline over the next 3 years.
Ingresos vs. Mercado: PFE's revenue is expected to decline over the next 3 years (-7.7% per year).
Ingresos de alto crecimiento: PFE's revenue is forecast to decline over the next 3 years (-7.7% per year).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if PFE's Return on Equity is forecast to be high in 3 years time